Herbas VPB

Spausdinti
EN | LT
LT - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
EN - REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE

Teisinis statusas

Patentas neįsigaliojo (pagal EPK)

Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
(51) INT.CL. C12N 5/0783 (2010.01)
A61K 39/0008 (2013.01)
A61K 39/00 (2006.01)
A61K 39/0011 (2013.01)
A61P 29/00 (2006.01)
C12N 5/0636 (2013.01)
A61P 37/00 (2006.01)
A61P 29/00 (2018.01)
A61P 37/00 (2018.01)
Europos patentas
(11) Patento numeris 3097923
(13) Dokumento rūšis T
(96) Europos patento paraiškos numeris 16177278.5
Europos patento paraiškos padavimo data 2008-01-31
(97) Europos patento paraiškos paskelbimo data 2016-11-30
(45) Paskelbimo apie Europos patento išdavimą data 2022-07-27
(46) Apibrėžties vertimo paskelbimo data
Prioriteto paraiškos
(30) Numeris Data Šalis
898408 P 2007-01-31 US
951052 P 2007-07-20 US
Išradėjai
(72)
ESHHAR, Zelig , IL
ELINAV, Eran , IL
Savininkas
(73) YEDA RESEARCH AND DEVELOPMENT CO., LTD. , The Weizmann Institute of Science, P.O. Box 95, 76100 Rehovot, IL
Pavadinimas
(54) REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
  REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE